Expanding the Reach of Antibody-Drug Conjugates

被引：47

作者：

Chari, Ravi V. J. ^{[1
]}

机构：

[1] ImmunoGen Inc, 830 Winter St, Waltham, MA 02451 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2016年 / 7卷 / 11期

关键词：

CANCER-THERAPY;

D O I：

10.1021/acsmedchemlett.6b00312

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Antibody-drug conjugates (ADCs) represent an emerging new paradigm in cancer therapy. The approval of two ADCs has spurred considerable interest in this area of research, and over 55 ADCs are currently in clinical testing. In order to improve the clinical success rate of ADC therapy, all three components of the ADC: the antibody, linker, and payload have to be optimized. While considerable improvements have been made in antibody properties and target selection, medicinal chemistry efforts have lagged behind, and there is a significant need for innovation in linker design and payloads.

引用

页码：974 / 976

页数：3

共 50 条

[21] Marine Antibody-Drug Conjugates: Design Strategies and Research Progress [J].

Wang, Yu-Jie ;

Li, Yu-Yan ;

Liu, Xiao-Yu ;

Lu, Xiao-Ling ;

Cao, Xin ;

Jiao, Bing-Hua .

MARINE DRUGS, 2017, 15 (01)

[22] Antibody-drug conjugates as novel anti-cancer chemotherapeutics [J].

Peters, Christina ;

Brown, Stuart .

BIOSCIENCE REPORTS, 2015, 35

[23] Prospects and progress of antibody-drug conjugates in solid tumor therapies [J].

Govindan, Serengulam V. ;

Sharkey, Robert M. ;

Goldenberg, David M. .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (07) :883-893

[24] Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates [J].

Bobaly, Balazs ;

Fleury-Souverain, Sandrine ;

Beck, Alain ;

Veuthey, Jean-Luc ;

Guillarme, Davy ;

Fekete, Szabolcs .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 147 :493-505

[25] Intratumoral Payload Concentration Correlates with the Activity of Antibody-Drug Conjugates [J].

Zhang, Donglu ;

Yu, Shang-Fan ;

Khojasteh, S. Cyrus ;

Ma, Yong ;

Pillow, Thomas H. ;

Sadowsky, Jack D. ;

Su, Dian ;

Kozak, Katherine R. ;

Xu, Keyang ;

Polson, Andrew G. ;

Dragovich, Peter S. ;

Hop, Cornelis E. C. A. .

MOLECULAR CANCER THERAPEUTICS, 2018, 17 (03) :677-685

[26] Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates [J].

Burke, Patrick J. ;

Hamilton, Joseph Z. ;

Pires, Thomas A. ;

Setter, Jocelyn R. ;

Hunter, Joshua H. ;

Cochran, Julia H. ;

Waight, Andrew B. ;

Gordon, Kristine A. ;

Toki, Brian E. ;

Emmerton, Kim K. ;

Zeng, Weiping ;

Stone, Ivan J. ;

Senter, Peter D. ;

Lyon, Robert P. ;

Jeffrey, Scott C. .

MOLECULAR CANCER THERAPEUTICS, 2016, 15 (05) :938-945

[27] Learn from antibody-drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy [J].

Wu, Mo ;

Huang, Wei ;

Yang, Nan ;

Liu, Yanyong .

EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)

[28] Adverse events of antibody-drug conjugates on the ocular surface in cancer therapy [J].

Dominguez-Llamas, Sandra ;

Caro-Magdaleno, Manuel ;

Mataix-Albert, Beatriz ;

Aviles-Prieto, Javier ;

Romero-Barranca, Isabel ;

Rodriguez-de-la-Rua, Enrique .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (11) :3086-3100

[29] Joint Disposition Properties and Comprehensive Pharmacokinetic Characterization of Antibody-Drug Conjugates [J].

Liao, Kai H. ;

Williams, Jason H. ;

Palani, Santhosh ;

Yin, Donghua ;

Meng, Xu .

AAPS JOURNAL, 2022, 24 (04)

[30] Recent progress in transglutaminase-mediated assembly of antibody-drug conjugates [J].

Schneider, Hendrik ;

Deweid, Lukas ;

Avrutina, Olga ;

Kolmar, Harald .

ANALYTICAL BIOCHEMISTRY, 2020, 595

← 1 2 3 4 5 →